Acrivon stock upgraded to Buy by Ladenburg Thalmann on cancer drug results By Investing.com

Acrivon Therapeutics Inc (NASDAQ: ACRV) has received an upgrade from Neutral to Buy by Ladenburg Thalmann, with a new price target set at $16. The upgrade follows Acrivon’s announcement of a 63% objective response rate (ORR) in a small study involving endometrial cancer patients who had not responded to or were ineligible for prior PD-1 … Read more

‘Beetlejuice Beetlejuice’ extends No. 1 reign for second weekend (NASDAQ:WBD)

Jacob Ammentorp Lund/iStock via Getty Images ‘Beetlejuice Beetlejuice’ for the second straight weekend was the No. 1 movie in North America, this time with $51.6 million in ticket sales, according to studio estimates Sunday. The Warner Bros. (NASDAQ:WBD) release added $28.7 million in international markets to lift its global total to $264.3 million. In second … Read more

£25k in savings? Here’s how I’d try and turn that into passive income worth £12k a year

Image source: Getty Images When I retire, which I expect will be at least a couple of decades from now, I hope to top up my pension earnings with passive income from my Stocks & Shares ISA. Collectively, these earnings could make my retirement more financially comfortable and enjoyable. For the last decade, I’ve been investing … Read more

Venezuela arrests Spain, U.S. and Czech nationals for ‘destabilization’ By Reuters

CARACAS (Reuters) -Two Spaniards, three U.S. citizens and a Czech have been arrested in Venezuela on suspicion of links to alleged plans to destabilize the South American country, a top Venezuela official said on Saturday. A spokesperson for the U.S. State Department said “a U.S. military member” had been detained in Venezuela and that it … Read more

GSK, iTeos lung cancer drug outperforms Jemperli (NASDAQ:ITOS)

koto_feja/E+ via Getty Images iTeos Therapeutics (NASDAQ:ITOS) announced Saturday that its experimental cancer doublet therapy developed with GSK (NYSE:GSK) outperformed the British drugmaker’s FDA-approved anti-PD-1 therapy dostarlimab, branded as Jemperli, in a mid-stage trial. Citing follow-up interim data generated from the study named GALAXIES Lung-201 trial, iTeos (ITOS) said that the experimental combo led to … Read more